The global lung cancer diagnostics market is experiencing significant growth, driven by rising incidence rates, technological advancements, and increased focus on early detection. In 2023, the market was valued at approximately USD 15.1 billion and is projected to reach around USD 34.8 billion by 2034, expanding at a compound annual growth rate (CAGR) of 7.9% during the forecast period from...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)